Profile
Jonathan D.
Alspaugh is President & Chief Strategy Officer at Rycarma Therapeutics, Inc. since 2024.
Formerly, Mr. Alspaugh was President, CEO, CFO & Chief Accounting Officer at Spyre Therapeutics, Inc. in 2023.
From 2013 to 2021, Mr. Alspaugh was Managing Director at Evercore, Inc. Education includes undergraduate and graduate degrees from the University of Michigan and an MBA from MIT Sloan School of Management.
Jonathan Alspaugh active positions
| Companies | Position | Start |
|---|---|---|
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | President | 2024-01-06 |
Former positions of Jonathan Alspaugh
| Companies | Position | End |
|---|---|---|
| EVERCORE INC. | Chief Executive Officer | 2021-05-31 |
| SPYRE THERAPEUTICS, INC. | Chief Executive Officer | - |
Training of Jonathan Alspaugh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Evercore, Inc.
Evercore, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Rycarma Therapeutics, Inc.
Rycarma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small-molecule therapeutics | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Jonathan Alspaugh
















